TARQUIN ALWATTAR: Open Payments
NPI 1619242393 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 22 payments from 10 companies in 2025. Trend: 2023 $813 · 2024 $734 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $178 |
| GENZYME CORPORATION | 8 | $170 |
| Arcutis Biotherapeutics, Inc. | 1 | $118 |
| Lilly USA, LLC | 3 | $94 |
| Incyte Corporation | 2 | $56 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $24 |
| LEO Pharma Inc. | 1 | $24 |
| Amgen Inc. | 1 | $15 |
| Organon LLC | 1 | $15 |
Products named: DUPIXENT, BOTOX, Zoryve, TALTZ, OPZELURA, SKYRIZI, Cabtreo, RINVOQ.
Industry payments across CA — which companies pay providers there.
